217 related articles for article (PubMed ID: 9058814)
1. The tetraspanin protein CD82 associates with both free HLA class I heavy chain and heterodimeric beta 2-microglobulin complexes.
Lagaudrière-Gesbert C; Lebel-Binay S; Wiertz E; Ploegh HL; Fradelizi D; Conjeaud H
J Immunol; 1997 Mar; 158(6):2790-7. PubMed ID: 9058814
[TBL] [Abstract][Full Text] [Related]
2. Invariant chain association with MHC class I: preference for HLA class I/beta 2-microglobulin heterodimers, specificity, and influence of the MHC peptide-binding groove.
Vigna JL; Smith KD; Lutz CT
J Immunol; 1996 Nov; 157(10):4503-10. PubMed ID: 8906828
[TBL] [Abstract][Full Text] [Related]
3. Supramolecular complexes of MHC class I, MHC class II, CD20, and tetraspan molecules (CD53, CD81, and CD82) at the surface of a B cell line JY.
Szöllósi J; Horejsí V; Bene L; Angelisová P; Damjanovich S
J Immunol; 1996 Oct; 157(7):2939-46. PubMed ID: 8816400
[TBL] [Abstract][Full Text] [Related]
4. The tetraspan protein CD82 is a resident of MHC class II compartments where it associates with HLA-DR, -DM, and -DO molecules.
Hammond C; Denzin LK; Pan M; Griffith JM; Geuze HJ; Cresswell P
J Immunol; 1998 Oct; 161(7):3282-91. PubMed ID: 9759843
[TBL] [Abstract][Full Text] [Related]
5. CD9, CD63, CD81, and CD82 are components of a surface tetraspan network connected to HLA-DR and VLA integrins.
Rubinstein E; Le Naour F; Lagaudrière-Gesbert C; Billard M; Conjeaud H; Boucheix C
Eur J Immunol; 1996 Nov; 26(11):2657-65. PubMed ID: 8921952
[TBL] [Abstract][Full Text] [Related]
6. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
Braud VM; Allan DS; O'Callaghan CA; Söderström K; D'Andrea A; Ogg GS; Lazetic S; Young NT; Bell JI; Phillips JH; Lanier LL; McMichael AJ
Nature; 1998 Feb; 391(6669):795-9. PubMed ID: 9486650
[TBL] [Abstract][Full Text] [Related]
7. Reduced expression of major histocompatibility complex class I free heavy chains and enhanced sensitivity to natural killer cells after incubation of human lymphoid lines with beta 2-microglobulin.
Carbone E; Stuber G; Andrée S; Franksson L; Klein E; Beretta A; Siccardi AG; Kärre K
Eur J Immunol; 1993 Aug; 23(8):1752-6. PubMed ID: 7688306
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the interactions between MHC class I subunits: a systematic approach for the engineering of higher affinity variants of beta 2-microglobulin.
Shields MJ; Assefi N; Hodgson W; Kim EJ; Ribaudo RK
J Immunol; 1998 Mar; 160(5):2297-307. PubMed ID: 9498770
[TBL] [Abstract][Full Text] [Related]
9. Class I HLA folding and antigen presentation in beta 2-microglobulin-defective Daudi cells.
Martayan A; Sibilio L; Tremante E; Lo Monaco E; Mulder A; Fruci D; Cova A; Rivoltini L; Giacomini P
J Immunol; 2009 Mar; 182(6):3609-17. PubMed ID: 19265139
[TBL] [Abstract][Full Text] [Related]
10. Excess beta 2 microglobulin promoting functional peptide association with purified soluble class I MHC molecules.
Kozlowski S; Takeshita T; Boehncke WH; Takahashi H; Boyd LF; Germain RN; Berzofsky JA; Margulies DH
Nature; 1991 Jan; 349(6304):74-7. PubMed ID: 1985269
[TBL] [Abstract][Full Text] [Related]
11. Cross-linking of insulin receptors to MHC antigens in human B lymphocytes: evidence for selective molecular interactions.
Samson M; Cousin JL; Fehlmann M
J Immunol; 1986 Oct; 137(7):2293-8. PubMed ID: 3531328
[TBL] [Abstract][Full Text] [Related]
12. Interaction of CD82 tetraspanin proteins with HTLV-1 envelope glycoproteins inhibits cell-to-cell fusion and virus transmission.
Pique C; Lagaudrière-Gesbert C; Delamarre L; Rosenberg AR; Conjeaud H; Dokhélar MC
Virology; 2000 Oct; 276(2):455-65. PubMed ID: 11040136
[TBL] [Abstract][Full Text] [Related]
13. EWI2/PGRL associates with the metastasis suppressor KAI1/CD82 and inhibits the migration of prostate cancer cells.
Zhang XA; Lane WS; Charrin S; Rubinstein E; Liu L
Cancer Res; 2003 May; 63(10):2665-74. PubMed ID: 12750295
[TBL] [Abstract][Full Text] [Related]
14. Conformation and surface expression of free HLA-CW1 heavy chains in the absence of beta 2-microglobulin.
Martayan A; Fiscella M; Setini A; Ciccarelli G; Gambari R; Feriotto G; Beretta A; Siccardi AG; Appella E; Giacomini P
Hum Immunol; 1997 Mar; 53(1):23-33. PubMed ID: 9127144
[TBL] [Abstract][Full Text] [Related]
15. Clustering of class I HLA molecules on the surfaces of activated and transformed human cells.
Matko J; Bushkin Y; Wei T; Edidin M
J Immunol; 1994 Apr; 152(7):3353-60. PubMed ID: 8144921
[TBL] [Abstract][Full Text] [Related]
16. Expression and characterization of recombinant single-chain salmon class I MHC fused with beta2-microglobulin with biological activity.
Zhao H; Stet RJ; Skjødt K; Savelkoul HF
Fish Shellfish Immunol; 2008 Apr; 24(4):459-66. PubMed ID: 18280180
[TBL] [Abstract][Full Text] [Related]
17. Peptide-induced conformational change of the class I heavy chain.
Elliott T; Cerundolo V; Elvin J; Townsend A
Nature; 1991 May; 351(6325):402-6. PubMed ID: 2034289
[TBL] [Abstract][Full Text] [Related]
18. Stable expression of MHC class I heavy chain/HLA-DO complexes at the plasma membrane.
van Lith M; van Ham M; Neefjes J
Eur J Immunol; 2003 May; 33(5):1145-51. PubMed ID: 12731039
[TBL] [Abstract][Full Text] [Related]
19. Amino acid composition of alpha1/alpha2 domains and cytoplasmic tail of MHC class I molecules determine their susceptibility to human cytomegalovirus US11-mediated down-regulation.
Barel MT; Pizzato N; van Leeuwen D; Bouteiller PL; Wiertz EJ; Lenfant F
Eur J Immunol; 2003 Jun; 33(6):1707-16. PubMed ID: 12778489
[TBL] [Abstract][Full Text] [Related]
20. Transmembrane-4 superfamily proteins CD81 (TAPA-1), CD82, CD63, and CD53 specifically associated with integrin alpha 4 beta 1 (CD49d/CD29).
Mannion BA; Berditchevski F; Kraeft SK; Chen LB; Hemler ME
J Immunol; 1996 Sep; 157(5):2039-47. PubMed ID: 8757325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
